Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision (v3.5.2) was added and an older revision (v3.5.0) was deleted.
    Difference
    0.2%
    Check dated 2026-04-16T10:55:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Record history shows only the initial version with no substantive edits; no additions or deletions are visible in the screenshot.
    Difference
    0.1%
    Check dated 2026-04-09T08:38:43.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T19:39:13.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and deleted Revision: v3.4.2 in the site’s revision history.
    Difference
    0.1%
    Check dated 2026-03-11T18:29:39.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the notice about a lapse in government funding and operating-status details was removed (the prior notice was v3.4.1).
    Difference
    0.9%
    Check dated 2026-02-11T10:28:20.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page version was updated from v3.4.0 to v3.4.1 and a site-wide notice about potential data delays due to a lapse in government funding was added.
    Difference
    0.9%
    Check dated 2026-02-04T05:58:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.